New EU research consortium with participation of GSH
The EUbOPEN consortium (Enabling and Unlocking Biology in the OPEN) aims to generate a comprehensive pharmacological drug library and make it accessible to the research community. The EU project of the Innovative Medicines Initiative (IMI2), which is funded for 5 years, is a collaboration of 22 institutions and pharmaceutical companies. At GSH, active ingredients are to be tested in patient-derived assays.